Attract talent

Laurence Mevellec

Director of Medicinal Chemistry

Dr. Laurence Mevellec is the inventor of BalversaTM, an FGFR inhibitor for the treatment of metastatic urothelial carcinoma, which has been available to the medical profession and patients since 2019.


Roles at NovAliX

  • Director of Medicinal Chemistry

    December, 2020 - present

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at NovAliX

My pet peeves

My communication style

Org chart

Direct reports

No reports


No teams

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.